|
Affymetrix's Q4 Sales Surge 13 Percent (GenomeWeb News)
NEW YORK (GenomeWeb News) – Affymetrix reported after the close of the market Wednesday that its fourth-quarter revenues increased 13 percent, driven by a 30 percent increase in sales of its genotyping products.
(Feb 3, 2010)
TGen Partners with Geisinger on Obesity Research (GenomeWeb News)
NEW YORK (GenomeWeb News) – The Translational Genomics Research Institute will partner with Geisinger Health System in Pennsylvania in an effort that will use genomics technologies and clinical data to discover causes of obesity, diabetes, and other metabolic conditions.
(Feb 3, 2010)
Penn Biologists Determine MicroRNA Activity Is Suppressed in Mouse Ovum (redOrbit)
Biologists at the University of Pennsylvania studying oocytes in mice, the immature egg cells necessary for sexual reproduction, have demonstrated an unusual behavior in microRNA, or miRNA, activity that may be the first event in reprogramming the differentiated oocyte into pluripotent blastomeres of the embryo.
(Feb 4, 2010)
SDSU Provides Web Tool for Plant Breeders (Newswise)
A new Web-based tool at South Dakota State University helps plant breeders & researchers worldwide analyze molecular data to select best grapes & other plant stock to breed better plants.
(Feb 4, 2010)
TGen, Geisinger Health System sign strategic research agreement (News-Medical-Net)
The Translational Genomics Research Institute (TGen) and Geisinger Health System today announced the signing of a strategic research agreement that provides for a focused look at the gaps in clinical medicine where biomedical research can make a difference.
(Feb 4, 2010)
P&G joins existing Navigenics investors in $18M Series C financing (News-Medical-Net)
Navigenics, a leading personal genomics company, announced today that the company has raised approximately $18 million of funding. The Procter and Gamble Company, with a worldwide portfolio of leading consumer brands, has joined existing Navigenics investors Kleiner Perkins Caufield and Byers and Mohr Davidow Ventures who also participated in this financing round.
(Feb 4, 2010)
Geisinger Health System and TGen sign research agreement (News-Medical-Net)
Geisinger Health System and the Translational Genomics Research Institute (TGen) today announced the signing of a strategic research agreement that provides a focused look at the gaps in clinical medicine where biomedical research can make a difference.
(Feb 4, 2010)
Pall Corporation Introduces The PallSep Biotech Filtration System For Difficult-To-Process Biotechnology Feed Streams (PharmaceuticalOnline)
Pall Corporation, a global leader in filtration, separation and purification, has introduced the PallSep Biotech system for the gentle separation of target molecules from complex biotechnology process fluids.
(Feb 4, 2010)
USPTO issues three patents to Rosetta Genomics (News-Medical-Net)
Rosetta Genomics today announced that the United States Patent and Trademark Office (USPTO) has issued three patents to the company covering the composition of matter of human microRNAs.
(Feb 4, 2010)
Pall Corporation Introduces The PallSep Biotech Filtration System For Difficult-To-Process Biotechnology Feed Streams (BioresearchOnline)
Pall Corporation, a global leader in filtration, separation and purification, has introduced the PallSep Biotech system for the gentle separation of target molecules from complex biotechnology process fluids.
(Feb 4, 2010)
Finland commits 1.85M as initial funding for development of European biomedical research infrastructures (News-Medical-Net)
Finland has made its first specific commitment to the development of European biomedical research infrastructures (BMS ESFRIs) by supporting a joint pilot infrastructure project in bioinformatics (ELIXIR), biobanking (BBMRI) and translational research (EATRIS). The initial commitment of 1.85 M- is to support preparation and pilot studies in 2010.
(Feb 4, 2010)
The Translational Genomics Research Institute Partners With Cambridge, UK, Firm In Cancer Research (Medical News Today)
The Translational Genomics Research Institute (TGen) and Horizon Discovery have announced plans to develop human disease models for use in TGen's cancer research. A research-collaboration and sub-licensing agreement will allow TGen investigators to use Horizon's GENESIS™ and X-MAN™ technologies to accelerate the search for new drug targets, biomarkers and anti-cancer agents, which could provide ...
(Feb 4, 2010)
Geisinger And TGen Announce Strategic Partnership To Shape Future Of Personalized Medicine (Medical News Today)
Geisinger Health System and the Translational Genomics Research Institute (TGen) announced the signing of a strategic research agreement that provides a focused look at the gaps in clinical medicine where biomedical research can make a difference. One of the first projects will focus on the causes of obesity, diabetes and other metabolic conditions. Researchers plan to look at the possible ...
(Feb 4, 2010)
Research and Markets: Bioinformatics for Glycobiology and Glycomics: an Introduction (Business Wire via Yahoo! Finance)
DUBLIN----Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Bioinformatics for Glycobiology and Glycomics: An Introduction" to their offering.
(Feb 4, 2010)
Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News (GenomeWeb News)
FDA granted the authorization in a Jan. 21 letter to Lee's Summit, Mo.-based ViraCor. The letter was made available ion the agency's web site this week.
(Feb 4, 2010)
GeneOhm to Acquire Infectio Diagnostic; Company Will Receive $12M VC Cash Infusion (GenomeWeb News)
NEW YORK, Oct. 21 (GenomeWeb News) - Microarray company GeneOhm Sciences will acquire Infectio Diagnostic in a stock swap expected to close in November, the firms said today.
(Feb 4, 2010)
Darwin's Handwriting Would Make Our Mothers Cry (GenomeWeb News)
"Darwin had difficult handwriting ," writes PZ Myers. The Darwin Online collection has digital versions of Charles Darwin's notes and letters. Taking a look at this outline of his species theory, Darwin's handwriting does indeed look spidery and small, with cross-outs and sideways notes.
(Feb 4, 2010)
What, No Big Names Could Make It? (GenomeWeb News)
Bill Gates, Eric Lander, Maynard Olson, Leena Peltonen, and George Church led a panel discussion on personal genomics at the University of Washington on Wednesday night, covering the state of genomics and the effect of studies linking genetic variation to disease.
(Feb 4, 2010)
What Else is New?, It Should Be Titled (GenomeWeb News)
A National Science Foundation report says the US is at risk of losing its status as a leader in science and technological innovation, says a New York Times article . As science and technology flourishes outside the US, domestic science education lags and many Americans remain ignorant of basic science -- or, refuse to accept basic scientific tenets like evolution and the Big Bang. The report ...
(Feb 4, 2010)
LabCorp Pens Cancer Dx-Development Deal With CancerGuide Diagnostics (GenomeWeb News)
According to CancerGuide, its initial tests will be designed to help physicians assess the risk of cancer recurrence and for therapy selection.
(Feb 4, 2010)
CAREERS: Making It Easy on the Reviewer (GenomeWeb News)
At Effect Measure, Revere takes a break from an all-consuming grant application to discuss how to make reading the proposal easy on the reviewer — which hopefully makes your application more successful . "My goal is always to write the grant in such a way that it writes its own review.
(Feb 4, 2010)
At Close to No Cost (GenomeWeb News)
George Whitesides discusses using paper-based devices for medical tests for use in the developing world and in conflict zones. Almutairi"s lab is focused on utilizing and advancing bionanotechnology to detect, treat and prevent diseases mitigating their huge social and economic costs.
(Feb 4, 2010)
Researcher to track spread of disease, malware and power outages (EurekAlert!)
( Virginia Tech ) An assistant professor with the Virginia Tech College of Engineering has won a Department of Energy Early Career Award to formulate a mathematical framework that can track the spread of pandemics among populations and malware across wireless computer networks, as well as how a blackout occurring on one major power grid can cause a cascade of additional neighboring networks to ...
(Feb 4, 2010)
This Week in Nature (GenomeWeb News)
In this week's issue of Nature , a UK research team reports that they have identified large, rare chromosomal copy number changes linked to early obesity . In a group of 300 Caucasian individuals with early onset obesity, including 143 with developmental delays, the researchers found recurrent, rare deletions of various sizes affecting a chromosome 16 region called 16p11.2 — previously tied to ...
(Feb 4, 2010)
Researcher to track spread of disease, malware and power outages (PhysOrg)
An assistant professor with the Virginia Tech College of Engineering has won a $750,000 federal grant to formulate a mathematical framework that can track the spread of pandemics among populations and malware across wireless computer networks, as well as how a blackout occurring on one major power grid can cause a cascade of additional neighboring networks to fail.
(Feb 4, 2010)
Product Watch (GenomeWeb News)
EMLab P&K, a TestAmerica company, has launched new analytical services to detect pathogens in food and environmental samples using real-time PCR technology.
(Feb 4, 2010)
QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients (Business Wire via Yahoo! Finance)
MANCHESTER, England & NEW YORK----Pfizer Inc. and DxS today announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 , an immunotherapy vaccine in development for the treatment of glioblastoma multiforme .
(Feb 4, 2010)
Luminex Corporation Reports Fourth Quarter and Full Year 2009 Results (PR Newswire via Yahoo! Finance)
Luminex Corporation today announced financial results for the fourth quarter and year ended December 31, 2009. Recent financial and operating highlights include the following:
(Feb 4, 2010)
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2009 (Business Wire via Yahoo! Finance)
SAN DIEGO----Illumina, Inc. today announced its financial results for the fourth quarter and fiscal year of 2009.
(Feb 4, 2010)
QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients (Finanzen.net)
Pfizer Inc. (NYSE: PFE) and DxS (a wholly owned subsidiary ...
(Feb 4, 2010)
Luminex Corporation Reports Fourth Quarter and Full Year 2009 Results (redOrbit)
AUSTIN, Texas, Feb. 4 /PRNewswire-FirstCall/ -- Luminex Corporation (Nasdaq: LMNX) today announced financial results for the fourth quarter and year ended December 31, 2009.
(Feb 4, 2010)
New computational tool for cancer treatment (Science Daily)
Researchers have developed an approach for creating new IDO inhibitors by computer-assisted structure-based drug design.
(Feb 4, 2010)
Centre to Tackle Big Issues in 2010 Research gathe (Scoop.co.nz)
A range of internationally recognised scientists, including Professor Sir Peter Gluckman, will address a range of cutting edge issues in reproductive and genetic science at the second Annual Scientific Research Colloquium held by the Centre for Reproduction and Genomics (CRG) a collaboration between the University of Otago and AgResearch, New Zealand’s leading primary industry research ...
(Feb 4, 2010)
Finland Commits $2.6M to European Research Infrastructure to Link Bfx, Biobanking, Translational Research (GenomeWeb News)
Finland has pledged $2.6 million (€1.85 M) to help develop European biomedical research infrastructure, which will help support a joint pilot infrastructure project in bioinformatics, biobanking, and translational research, the European Molecular Biology Laboratory said said in a statement.
(Feb 5, 2010)
Holloway competition jumpstarts student businesses (The New Hampshire)
By: Krista Macomber Now in its 22nd year, the Holloway Prize Innovation-to-Market Competition offers graduate and undergraduate students at the University of New Hampshire, Keene State College and Plymouth State University the chance to win up to $10,000 in seed money t...
(Feb 5, 2010)
Arrayit's VIP DNA testing technology receives patent protection in Israel (News-Medical-Net)
Arrayit Corporation, a life sciences and healthcare technology leader, announced today that the Company has received patent protection in the State of Israel for its proprietary Variation Identification Platform™ (VIP™) DNA testing technology. The Israeli patent extends Arrayit's current patent portfolio, which includes VIP patents in the United States, Singapore, New Zealand, China, South Korea ...
(Feb 5, 2010)
TGen finalizes alliance with Van Andel Research Institute (EurekAlert!)
( The Translational Genomics Research Institute ) The Translational Genomics Research Institute (TGen) today announced the completion of a strategic alliance and affiliation agreement with the Van Andel Research Institute (VARI) that will maximize the research capabilities of both nonprofit institutes.
(Feb 5, 2010)
TGen completes strategic alliance and affiliation agreement with VARI (News-Medical-Net)
The Translational Genomics Research Institute (TGen) today announced the completion of a strategic alliance and affiliation agreement with the Van Andel Research Institute (VARI) that will maximize the research capabilities of both non-profit institutes.
(Feb 5, 2010)
Virginia Tech professor wins grant to formulate mathematical framework for flu prevention (News-Medical-Net)
An assistant professor with the Virginia Tech College of Engineering has won a $750,000 federal grant to formulate a mathematical framework that can track the spread of pandemics among populations and malware across wireless computer networks, as well as how a blackout occurring on one major power grid can cause a cascade of additional neighboring networks to fail.
(Feb 5, 2010)
Results validating performance of GSN’s proprietary Parental Support technology published (News-Medical-Net)
Gene Security Network, Inc (GSN) today announced that Human Reproduction published results validating the exceptional performance of GSN’s proprietary Parental SupportTM technology over existing methods to detect chromosome abnormalities during in vitro-fertilization (IVF).
(Feb 5, 2010)
Press Release (PharmiWeb)
Pfizer Inc. Posted on:05 Feb 10 Pfizer Inc. (NYSE: PFE) and DxS (a wholly owned subsidiary of QIAGEN N.V.) (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the treatment of glioblastoma multiforme (GBM). Financial terms of the ...
(Feb 5, 2010)
Biomedical Research: Finland Invests 1.85 Million Euros In Pan-European Infrastructure (Medical News Today)
Finland has made its first specific commitment to the development of European biomedical research infrastructures (BMS ESFRIs) by supporting a joint pilot infrastructure project in bioinformatics (ELIXIR), biobanking (BBMRI) and translational research (EATRIS). The initial commitment of 1.85 M euros is to support preparation and pilot studies in 2010. This funding is meant to ensure Finland's ...
(Feb 5, 2010)
Gentium Announces an Abstract for Defibrotide in the Prevention of Hepatic VOD has been Granted the Prestigious Van ... (PR Newswire via Yahoo! Finance)
Gentium S.p.A. today announced that the abstract titled, "Defibrotide prevents hepatic VOD and reduces significantly VOD-associated complications in children at high risk: final results of a prospective phase II/III multicentre study," has been awarded the Van Bekkum Award for the best abstract submitted to the physician's program for the European Group for Blood and Marrow Transplantation's ...
(Feb 5, 2010)
TGen And Geisinger Health System Announce Strategic Partnership (Medical News Today)
The Translational Genomics Research Institute (TGen) and Geisinger Health System have announced the signing of a strategic research agreement that provides for a focused look at the gaps in clinical medicine where biomedical research can make a difference. One of the first projects will focus on the causes of obesity, diabetes and other metabolic conditions. Researchers plan to look at the ...
(Feb 5, 2010)
EBMT honours abstract on Defibrotide in Hepatic VOD prevention with the Van Bekkum Award (News-Medical-Net)
Gentium S.p.A. today announced that the abstract titled, "Defibrotide prevents hepatic VOD and reduces significantly VOD-associated complications in children at high risk: final results of a prospective phase II/III multicentre study," has been awarded the Van Bekkum Award for the best abstract submitted to the physician's program for the European Group for Blood and Marrow Transplantation's ...
(Feb 5, 2010)
NTU researchers complete the world's first in-depth study of the malaria parasite genome (EurekAlert!)
( Nanyang Technological University ) Groundbreaking research done at Singapore's Nanyang Technological University's School of Biological Sciences could lead to the development of more potent drugs or a vaccine for malaria. Assistant Professor Zbynek Bozdech and his team of researchers, including graduate students and post-doctorals from SBS' Division of Genomics & Genetics, have scored a world ...
(Feb 5, 2010)
SEC, Acacia, CombiMatrix, Korea NIH, Affymetrix, Nanogen, Aushon Biosystems, Oxford Gene Technology, RPCI, BlueGnome (GenomeWeb News)
The Securities and Exchange Commission has declared that Acacia Research and CombiMatrix can split apart on Aug. 15 after completing a share trade. At that date, every 10 shares of Acacia Research-CombiMatrix common stock will be redeemed for one share of CombiMatrix Corporation common stock.
(Feb 5, 2010)
A mossy renaissance (The Scientist)
The moss field wasn't getting enough respect, a group of researchers believed, and they decided to do something about it
(Feb 5, 2010)
Gentium Announces an Abstract for Defibrotide in the Prevention of Hepatic VOD has been Granted the Prestigious Van ... (redOrbit)
VILLA GUARDIA, Italy, Feb. 5 /PRNewswire-FirstCall/ -- Gentium S.p.A.
(Feb 5, 2010)
Illumina, Facing Dip in Array Demand, Posts 12-Percent Rise in Q4 Sales (GenomeWeb News)
"Significant growth" in demand for high-throughput sequencing products drove Illumina's fourth quarter sales up 12 percent year over year, offsetting a decline in array sales, the company said this week.
(Feb 5, 2010)
|
